Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,312 | 590,258 | 818,150 | 664,324 | 337,790 |
| Marketable Securities | 345,202 | N/A | N/A | N/A | N/A |
| Receivables | N/A | N/A | 22,228 | N/A | N/A |
| TOTAL | $397,770 | $596,475 | $847,338 | $669,276 | $342,273 |
| Non-Current Assets | |||||
| PPE Net | 11,179 | 11,604 | 4,912 | 2,996 | 1,445 |
| Other Non-Current Assets | 105,542 | 126,937 | 5,348 | 10,148 | 1,490 |
| TOTAL | $116,721 | $138,541 | $10,260 | $13,144 | $2,935 |
| Total Assets | $514,491 | $735,016 | $857,598 | $682,420 | $345,208 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,706 | 13,505 | 78,227 | 151,908 | 4,473 |
| Other current liabilities | 24,267 | 21,450 | 19,423 | 11,631 | 4,696 |
| TOTAL | $58,960 | $53,994 | $119,202 | $192,014 | $55,920 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 155,017 | 79,219 |
| Deferred Revenues | N/A | 1,648 | 4,688 | 4,701 | 31,335 |
| Other Non-Current Liabilities | 521,226 | 495,033 | 320,965 | 73,844 | 524 |
| TOTAL | $521,226 | $495,033 | $320,965 | $233,549 | $274,129 |
| Total Liabilities | $580,186 | $549,027 | $440,167 | $425,563 | $330,049 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,726 | 36,404 | 36,201 | 33,229 | 29,778 |
| Common Shares | 37 | 36 | 36 | 33 | 30 |
| Retained earnings | -1,567,532 | -1,255,631 | -958,245 | -710,493 | -420,323 |
| TOTAL | $-65,695 | $185,989 | $417,431 | $256,857 | $15,159 |
| Total Liabilities And Equity | $514,491 | $735,016 | $857,598 | $682,420 | $345,208 |